Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    15148277 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb
Condition: Lymphoma
Interventions: Drug: RCOMP;   Drug: RCHOP
2 Completed Prevention of Chemotherapy-Induced Cardiotoxicity in High-Risk Patients
Condition: Chemotherapy-Induced Cardiotoxicity Revealed by TnI Increase.
Intervention: Drug: oral enalapril

Indicates status has not been verified in more than two years